Business Description
Cigna Corp
NAICS : 524114
SIC : 6324
ISIN : IL0011716698
Share Class Description:
LIM:CI: Ordinary SharesCompare
Compare
Traded in other countries / regions
CI.USA0A77.UKCIGN.AustriaCGN.Germany1CI.ItalyCI.MexicoC1IC34.BrazilCI.Peru IPO Date
2020-11-18Description
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 0.76 | |||||
| Debt-to-EBITDA | 2.76 | |||||
| Interest Coverage | 5.64 | |||||
| Piotroski F-Score | 8/9 | |||||
| Beneish M-Score | -8.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.1 | |||||
| 3-Year EBITDA Growth Rate | 1.5 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 21.3 | |||||
| 3-Year Book Growth Rate | 0.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 10.59 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.93 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 11.9 | |||||
| 3-Year Average Share Buyback Ratio | 5.4 | |||||
| Shareholder Yield % | 6.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 1.98 | |||||
| EBITDA Margin % | 4.33 | |||||
| FCF Margin % | 2.36 | |||||
| ROE % | 12.23 | |||||
| ROA % | 3.26 | |||||
| ROIC % | 6.25 | |||||
| 3-Year ROIIC % | 9.96 | |||||
| Years of Profitability over Past 10-Year | 10 | |||||
| Moat score | 6 | |||||
| Tariff score | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.52 | |||||
| Forward PE Ratio | 19.44 | |||||
| PE Ratio without NRI | 12.11 | |||||
| Shiller PE Ratio | 20.29 | |||||
| Price-to-Owner-Earnings | 17.89 | |||||
| PS Ratio | 0.37 | |||||
| PB Ratio | 2.24 | |||||
| Price-to-Free-Cash-Flow | 15.33 | |||||
| Price-to-Operating-Cash-Flow | 12.41 | |||||
| EV-to-EBIT | 13.43 | |||||
| EV-to-EBITDA | 10.13 | |||||
| EV-to-Revenue | 0.44 | |||||
| EV-to-FCF | 18.57 | |||||
| Price-to-GF-Value | 0.75 | |||||
| Price-to-Projected-FCF | 0.61 | |||||
| Price-to-Median-PS-Value | 0.66 | |||||
| Earnings Yield (Greenblatt) % | 7.45 | |||||
| FCF Yield % | 6.73 | |||||
| Forward Rate of Return (Yacktman) % | 6.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cigna Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 254,465 | ||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 233.8 - 233.8 | ||
| Shares Outstanding (Mil) | 305.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cigna Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cigna Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cigna Corp Frequently Asked Questions
What is Cigna Corp(LIM:CI)'s stock price today?
The current price of LIM:CI is $233.80. The 52 week high of LIM:CI is $233.80 and 52 week low is $233.80.
When is next earnings date of Cigna Corp(LIM:CI)?
The next earnings date of Cigna Corp(LIM:CI) is 2025-07-31.
Does Cigna Corp(LIM:CI) pay dividends? If so, how much?
Cigna Corp(LIM:CI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers